Literature DB >> 26835363

Genetic causes of cancer predisposition in children and adolescents.

Federica Saletta1, Luciano Dalla Pozza1, Jennifer A Byrne1.   

Abstract

The acquisition of de novo somatic mutations accounts for approximately 90% of all new cancer diagnoses, while the remaining 10% is due to inherited genetic traits. In this latter category, individuals harbouring germline mutations show a higher likelihood of developing potentially life-threatening cancers, often at a very young age. The study of cancer genetics has profoundly helped our understanding of cancer biology, leading to better characterised malignancies, tailored targeted therapies and the identification of individuals at high risk of cancer diagnosis. This review will discuss examples of cancer syndromes in children, adolescents and young adults, the main underlying gene mutations, and the use of genetic testing to identify gene mutation carriers. Finally, we will describe how gene mutation detection is employed for the life-long management of patients with high susceptibility to cancer, including genetic counselling, increased surveillance, early intervention and use of targeted therapies.

Entities:  

Keywords:  Cancer predisposition; adolescents; childhood cancer; genetic testing

Year:  2015        PMID: 26835363      PMCID: PMC4729088          DOI: 10.3978/j.issn.2224-4336.2015.04.08

Source DB:  PubMed          Journal:  Transl Pediatr        ISSN: 2224-4336


  72 in total

1.  HRAS mutation mosaicism causing urothelial cancer and epidermal nevus.

Authors:  Christian Hafner; Agusti Toll; Francisco X Real
Journal:  N Engl J Med       Date:  2011-11-17       Impact factor: 91.245

2.  Biochemical and imaging surveillance in germline TP53 mutation carriers with Li-Fraumeni syndrome: a prospective observational study.

Authors:  Anita Villani; Uri Tabori; Joshua Schiffman; Adam Shlien; Joseph Beyene; Harriet Druker; Ana Novokmet; Jonathan Finlay; David Malkin
Journal:  Lancet Oncol       Date:  2011-05-19       Impact factor: 41.316

Review 3.  Surveillance for Wilms tumour in at-risk children: pragmatic recommendations for best practice.

Authors:  R H Scott; L Walker; Ø E Olsen; G Levitt; I Kenney; E Maher; C M Owens; K Pritchard-Jones; A Craft; N Rahman
Journal:  Arch Dis Child       Date:  2006-07-20       Impact factor: 3.791

4.  Trilateral retinoblastoma: a meta-analysis of hereditary retinoblastoma associated with primary ectopic intracranial retinoblastoma.

Authors:  T Kivelä
Journal:  J Clin Oncol       Date:  1999-06       Impact factor: 44.544

5.  Germline mutations in breast and ovarian cancer pedigrees establish RAD51C as a human cancer susceptibility gene.

Authors:  Alfons Meindl; Heide Hellebrand; Constanze Wiek; Verena Erven; Barbara Wappenschmidt; Dieter Niederacher; Marcel Freund; Peter Lichtner; Linda Hartmann; Heiner Schaal; Juliane Ramser; Ellen Honisch; Christian Kubisch; Hans E Wichmann; Karin Kast; Helmut Deissler; Christoph Engel; Bertram Müller-Myhsok; Kornelia Neveling; Marion Kiechle; Christopher G Mathew; Detlev Schindler; Rita K Schmutzler; Helmut Hanenberg
Journal:  Nat Genet       Date:  2010-04-18       Impact factor: 38.330

6.  Cooperativity of RUNX1 and CSF3R mutations in severe congenital neutropenia: a unique pathway in myeloid leukemogenesis.

Authors:  Julia Skokowa; Doris Steinemann; Jenny E Katsman-Kuipers; Cornelia Zeidler; Olga Klimenkova; Maksim Klimiankou; Murat Unalan; Siarhei Kandabarau; Vahagn Makaryan; Renee Beekman; Kira Behrens; Carol Stocking; Julia Obenauer; Susanne Schnittger; Alexander Kohlmann; Marijke G Valkhof; Remco Hoogenboezem; Gudrun Göhring; Dirk Reinhardt; Brigitte Schlegelberger; Martin Stanulla; Peter Vandenberghe; Jean Donadieu; C Michel Zwaan; Ivo P Touw; Marry M van den Heuvel-Eibrink; David C Dale; Karl Welte
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

7.  Hearing preservation surgery for neurofibromatosis Type 2-related vestibular schwannoma in pediatric patients.

Authors:  William H Slattery; Laurel M Fisher; William Hitselberger; Rick A Friedman; Derald E Brackmann
Journal:  J Neurosurg       Date:  2007-04       Impact factor: 5.115

8.  PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene.

Authors:  Nazneen Rahman; Sheila Seal; Deborah Thompson; Patrick Kelly; Anthony Renwick; Anna Elliott; Sarah Reid; Katarina Spanova; Rita Barfoot; Tasnim Chagtai; Hiran Jayatilake; Lesley McGuffog; Sandra Hanks; D Gareth Evans; Diana Eccles; Douglas F Easton; Michael R Stratton
Journal:  Nat Genet       Date:  2006-12-31       Impact factor: 38.330

9.  Down syndrome preleukemia and leukemia.

Authors:  Kelly W Maloney; Jeffrey W Taub; Yaddanapudi Ravindranath; Irene Roberts; Paresh Vyas
Journal:  Pediatr Clin North Am       Date:  2015-02       Impact factor: 3.278

10.  Sequence and structure signatures of cancer mutation hotspots in protein kinases.

Authors:  Anshuman Dixit; Lin Yi; Ragul Gowthaman; Ali Torkamani; Nicholas J Schork; Gennady M Verkhivker
Journal:  PLoS One       Date:  2009-10-16       Impact factor: 3.240

View more
  12 in total

Review 1.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

Review 2.  Parental Age and Childhood Lymphoma and Solid Tumor Risk: A Literature Review and Meta-Analysis.

Authors:  Allison Domingues; Kristin J Moore; Jeannette Sample; Harmeet Kharoud; Erin L Marcotte; Logan G Spector
Journal:  JNCI Cancer Spectr       Date:  2022-05-02

Review 3.  Advances in the Treatment of Pediatric Bone Sarcomas.

Authors:  Patrick J Grohar; Katherine A Janeway; Luke D Mase; Joshua D Schiffman
Journal:  Am Soc Clin Oncol Educ Book       Date:  2017

4.  Non-Random Selection of Cancer-Causing Mutations in Tissue-Specific Stem Cells Cause Cancer.

Authors:  Arnold J Levine
Journal:  J Clin Oncol Res       Date:  2020-09-22

5.  Maternal and Birth Characteristics and Childhood Embryonal Solid Tumors: A Population-Based Report from Brazil.

Authors:  Neimar de Paula Silva; Rejane de Souza Reis; Rafael Garcia Cunha; Júlio Fernando Pinto Oliveira; Marceli de Oliveira Santos; Maria S Pombo-de-Oliveira; Beatriz de Camargo
Journal:  PLoS One       Date:  2016-10-21       Impact factor: 3.240

6.  Application of genome analysis strategies in the clinical testing for pediatric diseases.

Authors:  Yaqiong Jin; Li Zhang; Baitang Ning; Huixiao Hong; Wenming Xiao; Weida Tong; Yiran Tao; Xin Ni; Tieliu Shi; Yongli Guo
Journal:  Pediatr Investig       Date:  2018-07-16

Review 7.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

8.  Identification of Genetic Predispositions Related to Ionizing Radiation in Primary Human Skin Fibroblasts From Survivors of Childhood and Second Primary Cancer as Well as Cancer-Free Controls: Protocol for the Nested Case-Control Study KiKme.

Authors:  Manuela Marron; Lara Kim Brackmann; Heike Schwarz; Willempje Hummel-Bartenschlager; Sebastian Zahnreich; Danuta Galetzka; Iris Schmitt; Christian Grad; Philipp Drees; Johannes Hopf; Johanna Mirsch; Peter Scholz-Kreisel; Peter Kaatsch; Alicia Poplawski; Moritz Hess; Harald Binder; Thomas Hankeln; Maria Blettner; Heinz Schmidberger
Journal:  JMIR Res Protoc       Date:  2021-11-11

9.  Increased burden of familial-associated early-onset cancer risk among minority Americans compared to non-Latino Whites.

Authors:  Qianxi Feng; Eric Nickels; Ivo S Muskens; Adam J de Smith; W James Gauderman; Amy C Yee; Charite Ricker; Thomas Mack; Andrew D Leavitt; Lucy A Godley; Joseph L Wiemels
Journal:  Elife       Date:  2021-06-22       Impact factor: 8.140

10.  Prevalence of germline pathogenic variants in 22 cancer susceptibility genes in Swedish pediatric cancer patients.

Authors:  Kristoffer von Stedingk; Karl-Johan Stjernfelt; Anders Kvist; Cecilia Wahlström; Ulf Kristoffersson; Marie Stenmark-Askmalm; Thomas Wiebe; Lars Hjorth; Jan Koster; Håkan Olsson; Ingrid Øra
Journal:  Sci Rep       Date:  2021-03-05       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.